Navigation Links
Drug-Device Combination Market Worth US$18.54 Billion by 2014
Date:7/28/2009

WILMINGTON, Delaware, July 28 /PRNewswire/ -- According to a new market research report, 'Drug-Device Combination Market (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total drug-device combination market is expected to be worth US$18.54 billion by 2014, out of which the U.S. market will account for nearly 30.9% of the total revenues. The global market is expected to record a CAGR of 11.8% from 2009 to 2014.

Browse 144 market data tables and in-depth TOC on drug-device market. Early buyers will receive 10% customization of reports

http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combinati

on-101.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug-device combination market ( http://www.marketsandmarkets.com/ Market-Reports/drug-and-device-combination-101.html ) includes all the products that are a combination of drugs and devices and can be chemically or physically united or co-packaged as separate, cross labeled products. The market is driven by the growing demand for treating only the ; targeted area, increasing incidences of infections associated with regular medical devices, need for faster healing, and overall reduced cost of treatment and accelerated approval process of the drug-device combination products.

(Due to the length of the URL in the above paragraph, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The drug eluting stents (DES) market is the larges
'/>"/>

SOURCE MarketsandMarkets
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
2. 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
3. Combination Therapy Best for Aggressive Prostate Cancer
4. Particle Sciences Further Expands Combination Product Development Capabilities
5. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
6. Abbotts TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
7. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
8. 2-drug combination appears safe and active in metastatic kidney cancer
9. New treatment combination proves safe for head and neck cancer patients
10. Study shows drug combination improves outcome for advanced non-small cell lung cancer
11. Chemotherapy combination outcomes differ for aged, younger colon cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... 2015 JJsHouse.com is a famous dress online ... business announces its latest collection of wedding dresses , ... important issue is the wedding dress on your big day; ... woman’s life. Every bride wants to find the most suitable ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... (NYSE: LDG ) today announced that its Board of ... $0.14 per share,payable on April 14, 2008 to stockholders of ... About the Company, Headquartered in Walnut Creek, California, Longs ... most recognized retail drug store,chains on the West Coast and ...
... the creature feared for attacks on people and pets ... scene investigators get a more accurate test for gunshot residue. ... rub-on medicines for stubborn antibiotic-resistant skin infections. Welcome to the ... hungry world. , Those are among hundreds of ...
... Reiterates 2008 Revenue Guidance of $50 Million, FORT ... ), leveraging the power of the Internet to bring ... for the quarter and twelve months ended December 31, ... quarter of 2007 were,$6.9 million, compared to $9.5 million ...
... not significantly , , TUESDAY, March 4 (HealthDay News) ... adding the chemotherapy drug gemcitabine to chemoradiation prolonged survival, ... study finds. , Among patients who have surgery to ... 85 percent rate of local relapse and a five-year ...
... Initiative points to continued need for mammograms , , TUESDAY, ... cancer lingers after a woman stops taking combination hormone replacement ... in the March 5 issue of the Journal of ... the landmark Women,s Health Initiative (WHI). That trial was halted ...
... MONROVIA, Calif., March 4 STAAR Surgical,Company (Nasdaq: ... marketer of,minimally invasive ophthalmic products, congratulates Dr. Brian ... Today Show this morning,correcting NBCSports.com columnist Alan Abrahamson,s ... ICL is the only foldable, minimally invasive lens ...
Cached Medicine News:Health News:News and features abound at ACS National Meeting in New Orleans, April 6-10 2Health News:News and features abound at ACS National Meeting in New Orleans, April 6-10 3Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 2Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 3Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 4Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 5Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 6Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 7Health News:Treatment Combo for Pancreatic Cancer Has Limited Benefit 2Health News:Raised Breast Cancer Risk Persists After Combo HRT Stopped 2Health News:Raised Breast Cancer Risk Persists After Combo HRT Stopped 3Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 2Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 3
(Date:1/23/2015)... 23, 2015   Leatt Corporation  (OTCQB: LEAT), a global ... all forms of sports, including extreme motor sports, and ... today that the UISP Lega Motociclismo Lombardia, an Italian ... to wear a neck brace during its racing competitions.  ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... ACG Annual Scientific Conference -, ORLANDO, ... today announced presentation of data from a ... cyclic guanosine,monophosphate (cGMP) plays in alleviating intestinal ... pain in a preclinical model of,intestinal hyperalgesia ...
... Likely to Induce Steroid-Free Remission and Mucosal Healing Compared ... ... the first time,from the Phase 3b Study of Patients with Crohn,s ... into,the approach to care of patients with moderate to severe Crohn,s ...
Cached Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8
... System is a single-use, ... thrombus removal in native ... vein grafts. Self-contained ... and,continuous evacuation. Available ...
... Healthcare's new Vivid 7 Dimension cardiovascular ultrasound ... give clinicians the first fully integrated real-time ... 7 Dimension, a latest member of the ... tools for detecting and diagnosing heart conditions ...
... The MyLab30CV ultrasound system is an evolutionary ... 20 pounds, it is the first compact ... And with mobile, portable or stationary configurations, ... MyLab30CV is the perfect combination of ...
... B-Twin Expandable Spinal System is intended for ... Implant - preloaded on its Delivery System ... space in a reduced configuration of 5 ... to 15mm (depending on the size selected) ...
Medicine Products: